home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Libris Britannia 4
/
science library(b).zip
/
science library(b)
/
MEDICAL
/
1211.ZIP
/
84
< prev
next >
Wrap
Text File
|
1987-10-07
|
604b
|
16 lines
IN PATIENTS WITH RENAL IMPAIRMENT, METOCLOPRAMIDE DOSAGE
SHOULD BE CAREFULLY ADJUSTED TO AVOID TOXICITY (SEDATION,
EXTRAPYRAMIDAL REACTIONS).
SOME CLINICIANS RECOMMEND THAT THE DOSAGE REGIMEN BE
ADJUSTED BASED ON THE PATIENT'S CREATININE CLEARANCE:
CREATININE DOSAGE REDUCTION
CLEARANCE METHOD
(ML/MINUTE)
10-50 75% of normal dose
<10 50% of normal dose